首页> 外文期刊>Expert opinion on therapeutic targets >Nephroprotective and clinical potential of statins in dialyzed patients.
【24h】

Nephroprotective and clinical potential of statins in dialyzed patients.

机译:他汀类药物在透析患者中​​的肾保护作用和临床潜力。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The combination of increased cardiovascular mortality and vascular complications due to dyslipidaemia in chronic kidney disease (CKD) has focused attention onto the potential beneficial effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA) inhibitors (statins) on the course of CKD. OBJECTIVE: To examine the use of statins in CKD. METHODS: A review of relevant literature. RESULTS/CONCLUSION: Current evidence from clinical trials in CKD patients on maintenance dialysis is limited. Therefore, the routine use of statins in this population remains the decision of individual physicians in discussion with their patients.
机译:背景:在慢性肾脏病(CKD)中,由于血脂异常而导致心血管疾病死亡率增加和血管并发症增加,已经将注意力集中在3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA)抑制剂(他汀类)的潜在有益作用上。在CKD的过程中。目的:研究他汀类药物在CKD中的使用。方法:相关文献综述。结果/结论:来自CKD患者维持性透析的临床试验的最新证据有限。因此,在这种人群中常规使用他汀类药物仍然是个别医师与患者讨论的决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号